Guofang Shen

Prof. Guofang Shen

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2024 in Processes
Verified
Journal Article
Open access
PDF file
JZJieqiang Zhu
Jieqiang Zhu
LSLisha Shen
Lisha Shen
GSGuofang Shen
Guofang Shen
YTYi Tao
Yi Tao
Achyranthes bidentata is always salt-processed before being prescribed for treating osteoarthritis. Yet the salt-processing parameters have not been optimized, and the specific bioactive constituents responsible for the osteoarthritis effect of salt-processed A. bidentata have not been fully elucidated. In this study, a Box–Behnken experimental design was chosen for the optimization of the salt-processing parameters of A. bidentata, including stir-frying time, concentration of brine, and soak time. Meanwhile, HPLC–Q-TOF-MS was utilized to analyze the chemical profiles of various batches of raw and salt-processed A. bidentata. The anti-inflammatory potential of nine batches of both raw and salt-processed A. bidentata was assessed via a cyclooxygenase-2 (COX-2) inhibitory assay. A gray correlation analysis was conducted to correlate the peak areas of the compounds in raw and salt-processed A. bidentata with their COX-2 inhibitory effects. Finally, the optimal salt-processing conditions are as follows: soak time: 29 min; concentration of brine: 1.8%; stir-frying time: 4.4 min. Twenty-nine compounds were identified. Eight compounds were found to have a strong positive correlation with anti-inflammatory activity, as confirmed by the COX-2 inhibitory assay. Notably, this is the first report of the COX-2 inhibitory effects of sanleng acid, stachysterone D, dihydroactinidiolide, N-cis-feruloyl-3-methoxytyramine, 9,12,13-trihydroxy-10-octadecenoic acid, azelaic acid, and dehydroecdysone.

15 April 2026 in Industrial Crops and Products
Verified
Journal Article
Open access
WLWei Li
Wei Li
LLLiang Liang
Liang Liang
XYXue Yan
Xue Yan
GSGuofang Shen
Guofang Shen
ZYZiang Yuan
Ziang Yuan
DYDongfeng Yang
Dongfeng Yang

9 June 2026 in Molecules
Verified
Journal Article
Open access
PDF file
SAShangxiao An
Shangxiao An
WZWeiyi Zheng
Weiyi Zheng
QTQi Tang
Qi Tang
GSGuofang Shen
Guofang Shen
Yi WangYi Wang
Yi Wang
YTYu Tang
Yu Tang
Quantitative 1H NMR (qNMR) is a versatile analytical tool that provides simultaneous structural and quantitative information without the need for analyte-specific standards. This review summarizes its key methodological fundamentals and broad applications in both pharmaceutical and biomedical analysis. In drug analysis, qNMR enables content determination and purity assessment of small molecules, polysaccharides and glycoconjugates, synthetic polymers, and complex herbal medicines. In biomedical analysis, it serves as a powerful platform for metabolomics profiling, real-time monitoring of cellular processes, and absolute quantification of metabolites in biofluids and tissues. Recent and emerging technological advancements, including hyperpolarization, quantum mechanical spectral analysis, artificial intelligence, and deep learning, hold great promise for further enhancing sensitivity, resolving power, and automation. With ongoing integration into pharmacopoeial standards and regulatory frameworks, qNMR is poised to expand its role in both routine quality control and cutting-edge biomedical research.

14 June 2026 in Applied Sciences
Verified
Journal Article
Open access
PDF file
CZCheng Zheng
Cheng Zheng
RZRui Zhu
Rui Zhu
SHShuyang Hua
Shuyang Hua
GSGuofang Shen
Guofang Shen
SZShujing Zhang
Shujing Zhang
Yi WangYi Wang
Yi Wang
Gao-shan-hong-jing-tian (GSHJT) Oral Liquid is a phytochemical-rich preparation derived from Rhodiola, yet its anti-hypoxic active constituents and molecular mechanisms remain poorly understood. This study aimed to identify the key anti-hypoxic phytochemicals in GSHJT Oral Liquid and clarify their mechanisms of action to support its potential use in managing acute mountain sickness (AMS). We first established and validated an HPLC method for quality control, then comprehensively profiled the chemical composition using LC-MS. Network pharmacology and molecular docking were applied to predict the core anti-hypoxic components, candidate targets and signaling pathways. The primary bioactivity was further verified through an in vitro carbonic anhydrase (CA) inhibition assay. A total of 71 constituents were identified, with kaempferol and ellagic acid emerging as the primary anti-hypoxic phytochemicals. These compounds target seven core proteins (SRC, PIK3R1, ESR1, EGFR, PTK2, IGF1R, and LYN) to regulate vascular tone, inflammation, oxidative stress, blood–brain barrier integrity, and cell survival under hypoxic conditions. By modulating pathways such as HIF-1α, PI3K/AKT, FAK/PTK2, SRC, and IGF1R, these phytochemicals ultimately influence the onset and alleviation of AMS. Enzyme inhibition assays demonstrated that kaempferol and ellagic acid inhibited CA with IC50 values of 34.05 μM and 119.1 μM, respectively. Molecular docking further revealed that both compounds suppressed CA activity through a combination of hydrogen bonding and hydrophobic interactions, consistent with a zinc-bound water-anchoring mechanism. This study elucidates the phytochemical basis and molecular mechanism responsible for the anti-hypoxic effects of GSHJT Oral Liquid, providing scientific support for its potential application as a natural, plant-derived intervention for preventing and alleviating acute mountain sickness, providing scientific support for its potential application and offering a reproducible paradigm for the rational development of other Rhodiola-based phytomedicines, though further in vivo validation is required to confirm the anti-hypoxic efficacy.

23 May 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YZYan Ziwei
Yan Ziwei
MLMinrui Li
Minrui Li
DLDan Li
Dan Li
WHWentian Hua
Wentian Hua
HCHaoxue Cao
Haoxue Cao
JQJIng Qian
JIng Qian
Background: The NLRP3 inflammasome drives pathological inflammation in various diseases. PINK1/Parkin-associated mitophagy serves as a critical negative regulator of NLRP3 activation, yet pharmacological enhancers remain scarce. Muscone, a natural macrocyclic ketone with blood–brain barrier permeability, exhibits potent anti-inflammatory properties; however, its mechanistic role within the NLRP3-mitophagy axis remains undefined. Methods: LPS/ATP-stimulated macrophages were employed to assess stage-specific effects of muscone on NLRP3 priming (NF-κB signaling, NLRP3, and pro-IL-1β expression) and activation (ASC oligomerization, ASC–pro-caspase 1 complex formation, and IL-1β secretion). RNA sequencing and bioinformatic analysis were performed for pathway enrichment. Mitophagy was characterized by MitoSOX Red staining for mt-ROS detection, electron microscopy, Western blotting of LC3B-II in isolated mitochondria and PINK1 and Parkin in whole-cell lysates, and live-cell mitochondria–lysosome tracking. In vivo protective efficacy was assessed in an LPS-induced endotoxemia mouse model. Results: Muscone dose-dependently suppressed both the priming and activation stages of the NLRP3 inflammasome, maximally reducing IL-1β secretion by ~60% at 50 μM. Mechanistically, muscone amplified PINK1/Parkin-associated mitophagy, scavenging excessive mt-ROS and attenuating NLRP3 activation. These effects were corroborated by RNA-seq and comprehensive functional assays. In vivo, muscone (30 mg/kg) significantly improved survival (3/8 mice alive at 98 h when all LPS controls had died; 2/8 survived to the 132-h endpoint), with concomitant enhancement of mitophagy markers in peritoneal macrophages. Conclusions: Muscone functions as a PINK1/Parkin-associated mitophagy enhancer that maintains mitochondrial quality control during NLRP3-driven inflammatory responses. Its unique macrocyclic structure and blood–brain barrier permeability provide a promising scaffold for developing therapeutics against inflammatory disorders associated with NLRP3 inflammasome activation.

19 March 2026 in Food Chemistry
Verified
Journal Article
Closed access
JXJing Xue
Jing Xue
ZHZiyang Hu
Ziyang Hu
HCHongjie Chen
Hongjie Chen
JWJiaqi Wang
Jiaqi Wang
XYXiaoping Yang
Xiaoping Yang
QSQing Shen
Qing Shen